KADCYLA
RxNorm concept 1371046, brand name (bn).
- RxCUI
- 1371046
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1371046 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- ado-trastuzumab emtansine (PIN, has precise ingredient)
- KADCYLA Injectable Product (SBDG, ingredient of)
- ado-trastuzumab emtansine 100 MG [KADCYLA] (SBDC, ingredient of)
- trastuzumab Injection [KADCYLA] (SBDF, ingredient of)
- ado-trastuzumab emtansine 100 MG Injection [KADCYLA] (SBD, ingredient of)
- ado-trastuzumab emtansine 160 MG [KADCYLA] (SBDC, ingredient of)
- ado-trastuzumab emtansine 160 MG Injection [KADCYLA] (SBD, ingredient of)
- trastuzumab (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1371046 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1371046 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1371046. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.